The 79th World Health Assembly has adopted the first-ever resolution on steatotic liver disease (SLD), marking a significant milestone in global noncommunicable disease (NCD) policy. The decision reflects a growing recognition that liver health is central to understanding and addressing the worldwide rise in metabolic diseases.
Steatotic liver disease is estimated to affect around 1.7 billion people globally and is closely linked with obesity, type 2 diabetes, cardiovascular disease, and alcohol-related harm. Experts now view it not as an isolated condition but as an early indicator of broader metabolic dysfunction.
Health experts highlight that fat accumulation in the liver often appears long before serious conditions such as cirrhosis, liver cancer, or advanced diabetes develop. In many cases, routine tools like blood tests, non-invasive fibrosis scoring systems such as FIB-4, and imaging techniques can detect early liver damage during standard primary care visits.
Despite this, liver health is still often excluded from mainstream NCD strategies. As a result, many patients are diagnosed only at advanced stages, missing critical opportunities for early intervention. The lack of integration between primary care, diabetes management, cardiology, and hepatology continues to delay prevention efforts.
The new global focus on steatotic liver disease highlights a broader shift toward integrated healthcare systems. Recent research shows that tools for early detection already exist, but they are not consistently applied across healthcare settings. Embedding liver health assessments into routine care for obesity and diabetes could help identify at-risk patients earlier and reduce long-term complications.
Public health experts argue that stronger integration of liver health into national NCD strategies could reduce hospitalizations, lower the burden of liver cancer, and improve outcomes for related metabolic diseases. The WHA resolution is seen as an important step toward aligning policy with existing scientific evidence.
As global health systems continue to face rising rates of chronic disease, the inclusion of liver health in prevention frameworks signals a broader shift toward earlier, more connected, and more effective metabolic care.
